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ABSTRACT
Modern radiation oncology is constantly improving and becoming more complex.
Novel dosimetric planning, delivery and dosimetry techniques have allowed for im-
proved plan quality and condence in delivery. This thesis is an investigation into
the impacts of novel radiotherapy planning and delivery techniques and the ecacy of
novel dosimetry methods for modern, complex radiotherapy.
The rst part of the thesis involved investigation into novel treatment planning
optimisation techniques for prostate cancer radiotherapy. Advantages and disadvan-
tages of IMRT for simple prostate radiotherapy in the Australian clinical setting is
investigated, showing small gains compared with high quality conformal radiotherapy.
The use of a radiobiological parameter, specically the generalised Equivalent Uniform
Dose (gEUD) was investigated for prostate IMRT optimisation to reduce rectal dose.
The gEUD metric was found to be a useful optimisation objective that provided rectal
dose reductions over the full dose range. The result of the optimisation was heavily
dependent on the value of a (describing organ architecture), with a lower value of a
resulting in the largest reductions in rectal dose. A commercial Volumetric Modulated
Arc Radiotherapy (VMAT) tool was investigated for prostate radiotherapy. Single arc
VMAT plans were compared to static gantry angle IMRT plans for prostate cancer
cases. It was found that VMAT resulted in equivalent target coverage with reductions
in rectal V25Gy. The VMAT plans required on average 18.6% fewer monitor units
and were theoretically up to 3.75 times faster to delivery compared with static gantry
angle IMRT.
The second part of the thesis looked at using modern radiation detectors for veri-
cation of treatment dose in regions of electronic disequilibrium. Rectal balloons lled
with air are used for prostate immobilisation and rectal dose reduction in prostate
photon radiotherapy. This introduces an air cavity into the patient, immediately
adjacent to the target. Radiochromic lm was used to show that two commercial con-
volution/superposition dose calculation algorithms slightly over-predict the anterior
rectal wall dose and under-predict the posterior rectal wall dose. The feasibility of
a novel MOSFET detector, the MOSkin, coupled to a commercial rectal balloon was
investigated for real time in vivo rectal wall dose verication. In this phantom study,
the MOSkin was shown to be an excellent real time dosimeter, with minimal angular
response and reproducible sensitivity. The MOSkin was then used with radiochromic
lm to verify the dose delivered to the skin during total scalp irradiation with helical
tomotherapy. It was shown that the helical tomotherapy RTPS accurately calculated
the dose to surface voxels and that the dose delivered to the skin is less than the
prescription dose, which suggests a bolus may be required to achieve prescription dose
to the skin. Finally, the dosimetric eect of end leaf leakage was investigated for a
commercial multileaf collimator for wide-eld IMRT. It was shown that end leaf leak-
age can contribute signicant doses to treatment elds, but provided the eects are
quantied it is reasonable to accept these as the allowance of wide elds avoids com-
plicated dual overlapping eld feathering. The commercial RTPS investigated slightly
under-predicts the magnitude of these end leaf leakage dose contributions.
KEYWORDS: IMRT, tomotherapy, radiochromic lm, radiobiological IMRT
optimisation, MOSFET detectors
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